Quest Diagnostics Incorporated (0KSX.L)
USD 158.08
(-5.6%)
USD 158.08
(-5.6%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 7.6 Billion USD | 11.33% |
| 2022 | 6.83 Billion USD | -3.11% |
| 2021 | 7.04 Billion USD | -1.21% |
| 2020 | 7.13 Billion USD | 0.78% |
| 2019 | 7.08 Billion USD | 25.11% |
| 2018 | 5.65 Billion USD | 3.49% |
| 2017 | 5.46 Billion USD | 1.96% |
| 2016 | 5.36 Billion USD | 3.55% |
| 2015 | 5.17 Billion USD | -6.63% |
| 2014 | 5.54 Billion USD | 11.5% |
| 2013 | 4.97 Billion USD | -2.41% |
| 2012 | 5.09 Billion USD | -8.94% |
| 2011 | 5.59 Billion USD | 25.14% |
| 2010 | 4.47 Billion USD | -1.73% |
| 2009 | 4.55 Billion USD | -5.14% |
| 2008 | 4.79 Billion USD | -8.44% |
| 2007 | 5.24 Billion USD | 98.37% |
| 2006 | 2.64 Billion USD | 3.9% |
| 2005 | 2.54 Billion USD | 32.79% |
| 2004 | 1.91 Billion USD | 0.44% |
| 2003 | 1.9 Billion USD | 22.59% |
| 2002 | 1.55 Billion USD | -2.46% |
| 2001 | 1.59 Billion USD | -13.0% |
| 2000 | 1.83 Billion USD | -9.06% |
| 1999 | 2.01 Billion USD | 154.37% |
| 1998 | 792.3 Million USD | -7.79% |
| 1997 | 859.2 Million USD | 0.33% |
| 1996 | 856.34 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 7.14 Billion USD | -3.54% |
| 2024 Q1 | 7.4 Billion USD | -2.58% |
| 2024 Q3 | 9.17 Billion USD | 28.38% |
| 2023 Q3 | 6.94 Billion USD | -1.67% |
| 2023 Q2 | 7.06 Billion USD | 6.52% |
| 2023 FY | 7.6 Billion USD | 11.33% |
| 2023 Q4 | 7.6 Billion USD | 9.52% |
| 2023 Q1 | 6.62 Billion USD | -2.94% |
| 2022 FY | 6.83 Billion USD | -3.11% |
| 2022 Q3 | 6.87 Billion USD | 1.31% |
| 2022 Q4 | 6.83 Billion USD | -0.64% |
| 2022 Q1 | 6.94 Billion USD | -1.42% |
| 2022 Q2 | 6.78 Billion USD | -2.36% |
| 2021 Q4 | 7.04 Billion USD | -0.17% |
| 2021 Q3 | 7.06 Billion USD | 3.19% |
| 2021 FY | 7.04 Billion USD | -1.21% |
| 2021 Q1 | 7.06 Billion USD | -1.02% |
| 2021 Q2 | 6.84 Billion USD | -3.1% |
| 2020 Q2 | 7.03 Billion USD | 12.15% |
| 2020 Q3 | 7.61 Billion USD | 8.32% |
| 2020 FY | 7.13 Billion USD | 0.78% |
| 2020 Q1 | 6.27 Billion USD | -11.44% |
| 2020 Q4 | 7.13 Billion USD | -6.33% |
| 2019 Q4 | 7.08 Billion USD | 12.58% |
| 2019 FY | 7.08 Billion USD | 25.11% |
| 2019 Q1 | 6.51 Billion USD | 15.2% |
| 2019 Q2 | 6.17 Billion USD | -5.28% |
| 2019 Q3 | 6.28 Billion USD | 1.85% |
| 2018 Q3 | 5.54 Billion USD | 2.51% |
| 2018 FY | 5.65 Billion USD | 3.49% |
| 2018 Q4 | 5.65 Billion USD | 2.07% |
| 2018 Q2 | 5.4 Billion USD | -2.59% |
| 2018 Q1 | 5.55 Billion USD | 1.54% |
| 2017 FY | 5.46 Billion USD | 1.96% |
| 2017 Q2 | 5.35 Billion USD | -0.19% |
| 2017 Q1 | 5.36 Billion USD | 0.09% |
| 2017 Q4 | 5.46 Billion USD | -1.17% |
| 2017 Q3 | 5.53 Billion USD | 3.27% |
| 2016 FY | 5.36 Billion USD | 3.55% |
| 2016 Q1 | 5.35 Billion USD | 3.48% |
| 2016 Q2 | 5.46 Billion USD | 2.0% |
| 2016 Q3 | 5.4 Billion USD | -1.15% |
| 2016 Q4 | 5.36 Billion USD | -0.74% |
| 2015 Q1 | 6.34 Billion USD | 14.33% |
| 2015 Q3 | 5.38 Billion USD | 0.15% |
| 2015 Q4 | 5.17 Billion USD | -3.81% |
| 2015 FY | 5.17 Billion USD | -6.63% |
| 2015 Q2 | 5.37 Billion USD | -15.23% |
| 2014 Q3 | 5.59 Billion USD | -0.83% |
| 2014 FY | 5.54 Billion USD | 11.5% |
| 2014 Q1 | 5.53 Billion USD | 11.16% |
| 2014 Q2 | 5.63 Billion USD | 1.95% |
| 2014 Q4 | 5.54 Billion USD | -0.79% |
| 2013 Q2 | 5.09 Billion USD | 0.37% |
| 2013 Q4 | 4.97 Billion USD | -1.6% |
| 2013 Q3 | 5.05 Billion USD | -0.82% |
| 2013 Q1 | 5.07 Billion USD | -0.38% |
| 2013 FY | 4.97 Billion USD | -2.41% |
| 2012 FY | 5.09 Billion USD | -8.94% |
| 2012 Q1 | 5.55 Billion USD | -0.77% |
| 2012 Q2 | 5.37 Billion USD | -3.3% |
| 2012 Q3 | 5.12 Billion USD | -4.67% |
| 2012 Q4 | 5.09 Billion USD | -0.45% |
| 2011 Q3 | 5.78 Billion USD | -3.33% |
| 2011 Q1 | 5.75 Billion USD | 28.55% |
| 2011 FY | 5.59 Billion USD | 25.14% |
| 2011 Q4 | 5.59 Billion USD | -3.17% |
| 2011 Q2 | 5.98 Billion USD | 4.0% |
| 2010 Q1 | 4.58 Billion USD | 0.77% |
| 2010 FY | 4.47 Billion USD | -1.73% |
| 2010 Q3 | 4.57 Billion USD | 0.96% |
| 2010 Q4 | 4.47 Billion USD | -2.3% |
| 2010 Q2 | 4.53 Billion USD | -1.14% |
| 2009 FY | 4.55 Billion USD | -5.14% |
| 2009 Q1 | 4.81 Billion USD | 0.32% |
| 2009 Q2 | 4.44 Billion USD | -7.65% |
| 2009 Q3 | 4.42 Billion USD | -0.41% |
| 2009 Q4 | 4.55 Billion USD | 2.81% |
| 2008 Q1 | 5.14 Billion USD | -1.85% |
| 2008 FY | 4.79 Billion USD | -8.44% |
| 2008 Q4 | 4.79 Billion USD | -0.78% |
| 2008 Q2 | 4.89 Billion USD | -4.76% |
| 2008 Q3 | 4.83 Billion USD | -1.28% |
| 2007 FY | 5.24 Billion USD | 98.37% |
| 2007 Q1 | 3.15 Billion USD | 19.49% |
| 2007 Q3 | 5.25 Billion USD | -0.95% |
| 2007 Q4 | 5.24 Billion USD | -0.25% |
| 2007 Q2 | 5.3 Billion USD | 68.01% |
| 2006 Q2 | 2.54 Billion USD | -0.96% |
| 2006 Q3 | 2.63 Billion USD | 3.6% |
| 2006 Q4 | 2.64 Billion USD | 0.23% |
| 2006 Q1 | 2.56 Billion USD | 1.03% |
| 2006 FY | 2.64 Billion USD | 3.9% |
| 2005 Q3 | 1.7 Billion USD | -1.17% |
| 2005 Q4 | 2.54 Billion USD | 48.98% |
| 2005 Q2 | 1.72 Billion USD | 1.37% |
| 2005 Q1 | 1.7 Billion USD | -11.02% |
| 2005 FY | 2.54 Billion USD | 32.79% |
| 2004 FY | 1.91 Billion USD | 0.44% |
| 2004 Q4 | 1.91 Billion USD | -0.11% |
| 2004 Q3 | 1.91 Billion USD | 0.51% |
| 2004 Q2 | 1.9 Billion USD | 1.7% |
| 2004 Q1 | 1.87 Billion USD | -1.63% |
| 2003 FY | 1.9 Billion USD | 22.59% |
| 2003 Q4 | 1.9 Billion USD | 1.45% |
| 2003 Q3 | 1.87 Billion USD | 0.33% |
| 2003 Q2 | 1.87 Billion USD | -3.61% |
| 2003 Q1 | 1.94 Billion USD | 24.94% |
| 2002 Q4 | 1.55 Billion USD | -13.01% |
| 2002 FY | 1.55 Billion USD | -2.46% |
| 2002 Q3 | 1.78 Billion USD | -4.97% |
| 2002 Q2 | 1.88 Billion USD | 20.6% |
| 2002 Q1 | 1.56 Billion USD | -2.16% |
| 2001 Q3 | 1.69 Billion USD | -2.71% |
| 2001 FY | 1.59 Billion USD | -13.0% |
| 2001 Q4 | 1.59 Billion USD | -5.68% |
| 2001 Q1 | 1.8 Billion USD | -1.57% |
| 2001 Q2 | 1.73 Billion USD | -3.68% |
| 2000 Q1 | 1.94 Billion USD | -3.66% |
| 2000 Q2 | 1.99 Billion USD | 2.78% |
| 2000 Q4 | 1.83 Billion USD | -9.25% |
| 2000 FY | 1.83 Billion USD | -9.06% |
| 2000 Q3 | 2.01 Billion USD | 1.2% |
| 1999 Q4 | 2.01 Billion USD | 2.27% |
| 1999 FY | 2.01 Billion USD | 154.37% |
| 1999 Q1 | 740.9 Million USD | -6.49% |
| 1999 Q2 | 715 Million USD | -3.5% |
| 1999 Q3 | 1.97 Billion USD | 175.61% |
| 1998 FY | 792.3 Million USD | -7.79% |
| 1998 Q4 | 792.3 Million USD | -1.55% |
| 1998 Q1 | 852.1 Million USD | -0.83% |
| 1998 Q3 | 804.8 Million USD | 0.16% |
| 1998 Q2 | 803.5 Million USD | -5.7% |
| 1997 Q4 | 859.2 Million USD | 0.48% |
| 1997 Q2 | 836 Million USD | -0.38% |
| 1997 Q1 | 839.2 Million USD | -1.96% |
| 1997 FY | 859.2 Million USD | 0.33% |
| 1997 Q3 | 855.1 Million USD | 2.28% |
| 1996 Q4 | 856 Million USD | -51.2% |
| 1996 Q3 | 1.75 Billion USD | 0.0% |
| 1996 FY | 856.34 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -6255.946% |
| Accuray Incorporated | 423.54 Million USD | -1695.331% |
| Align Technology, Inc. | 2.45 Billion USD | -209.939% |
| Elevance Health Inc. | 69.52 Billion USD | 89.063% |
| AxoGen, Inc. | 101.16 Million USD | -7416.656% |
| Boston Scientific Corporation | 15.6 Billion USD | 51.275% |
| CVS Health Corporation | 173.09 Billion USD | 95.607% |
| Cardinal Health, Inc. | 48.33 Billion USD | 84.267% |
| Centene Corporation | 58.68 Billion USD | 87.043% |
| DaVita Inc. | 14.87 Billion USD | 48.885% |
| HCA Healthcare, Inc. | 55.15 Billion USD | 86.212% |
| Hologic, Inc. | 4.02 Billion USD | -88.872% |
| Humana Inc. | 30.74 Billion USD | 75.269% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -328.299% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | 13.929% |
| Masimo Corporation | 1.67 Billion USD | -353.51% |
| McKesson Corporation | 69.04 Billion USD | 88.986% |
| Patterson Companies, Inc. | 1.89 Billion USD | -301.266% |
| ResMed Inc. | 2 Billion USD | -278.619% |
| Henry Schein, Inc. | 5.42 Billion USD | -40.295% |
| Teladoc Health, Inc. | 2.06 Billion USD | -268.001% |
| Universal Health Services, Inc. | 8.15 Billion USD | 6.756% |
| Veeva Systems Inc. | 1.26 Billion USD | -500.586% |
| Baxter International Inc. | 19.8 Billion USD | 61.611% |
| Becton, Dickinson and Company | 26.98 Billion USD | 71.82% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -271.979% |
| Danaher Corporation | 30.99 Billion USD | 75.469% |
| Stryker Corporation | 21.31 Billion USD | 64.332% |
| Medtronic plc | 39.56 Billion USD | 80.779% |